Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_02199 |
| Species: | Mus musculus |
| Position : | chr8:32199690-32200290 |
| Year: | 2023 |
| Title: | Epigenetic regulation of Neuregulin 1 promotes breast cancer progression associated to hyperglycemia |
| Genome Build: | mm10 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | breast cancer |
| PMID: | 36707514 |
| MONDO: | MONDO:0006120 |
| Tissue: | Mammary gland |
| Tissue Ontology ID: | UBERON:0001911 |
| Cell Source: | Met1 |
| CVCL ID: | CVCL_UP55 |
| Cell Type: | breast carcinoma cell |
| Cell Ontology ID: | CL:0000646 |
| Experiment Type: | Enhancer activity assay, TF binding assay, Functional perturbation assay |
| High Throughput Method: | FAIRE-seq, RNA-seq |
| Low Throughput Method: | Luciferase Reporter Assay, ChIP-RT-qPCR, CRISPR Knockout, qRT-PCR, Western blot |
| Target gene : | Nrg1 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|